These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 18289057)
21. Optimization of hypolipidemic and antiplatelet treatment in the diabetic patient with renal disease. Trovati M; Cavalot F J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S12-20. PubMed ID: 14684665 [TBL] [Abstract][Full Text] [Related]
22. [Pharmacy clinics. How I treat... A patient with hypertriglyceridemia]. Scheen AJ Rev Med Liege; 1995 Jun; 50(6):237-8. PubMed ID: 7617998 [No Abstract] [Full Text] [Related]
24. Synthesis and hypolipidemic activity of N-substituted phthalimides. Part V. Sena VL; Srivastava RM; Silva RO; Lima VL Farmaco; 2003 Dec; 58(12):1283-8. PubMed ID: 14630240 [TBL] [Abstract][Full Text] [Related]
27. Serial renal function and angiographic observations in idiopathic fibrous and fibromuscular stenoses of the renal arteries. Sheps SG; Kincaid OW; Hunt JC Am J Cardiol; 1972 Jul; 30(1):55-60. PubMed ID: 5035572 [No Abstract] [Full Text] [Related]
28. Paeoniflorin Promotes Angiogenesis in A Vascular Insufficiency Model of Zebrafish in vivo and in Human Umbilical Vein Endothelial Cells in vitro. Xin QQ; Yang BR; Zhou HF; Wang Y; Yi BW; Cong WH; Lee SM; Chen KJ Chin J Integr Med; 2018 Jul; 24(7):494-501. PubMed ID: 27286711 [TBL] [Abstract][Full Text] [Related]
29. Aggressive lipid-lowering therapy beneficial after bypass grafting, say researchers. Am J Health Syst Pharm; 1997 Mar; 54(6):626. PubMed ID: 9075489 [No Abstract] [Full Text] [Related]
30. Growth factors for therapeutic angiogenesis in peripheral arterial disease. Jones WS; Annex BH Curr Opin Cardiol; 2007 Sep; 22(5):458-63. PubMed ID: 17762548 [TBL] [Abstract][Full Text] [Related]
32. Improvement in renal cholesterol emboli syndrome after simvastatin. Woolfson RG; Lachmann H Lancet; 1998 May; 351(9112):1331-2. PubMed ID: 9643803 [No Abstract] [Full Text] [Related]
33. Notes on 'Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients' by Righetti M et al. Malnick S; Goland S Med Sci Monit; 2003 May; 9(5):LE12; author reply LE12-3. PubMed ID: 12852394 [No Abstract] [Full Text] [Related]
34. [On the treatment of cerebral and peripheral arterial obliterating vascular disorders with Tebonin]. Gau HP Arztl Forsch; 1969; 23(3):103-11. PubMed ID: 5819754 [No Abstract] [Full Text] [Related]
36. Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease. Blinc A; Poredos P Eur J Clin Invest; 2007 Mar; 37(3):157-64. PubMed ID: 17359482 [TBL] [Abstract][Full Text] [Related]
37. Increasing HDL levels by inhibiting cholesteryl ester transfer protein activity in rabbits with hindlimb ischemia is associated with increased angiogenesis. Wu BJ; Shrestha S; Ong KL; Johns D; Dunn LL; Hou L; Barter PJ; Rye KA Int J Cardiol; 2015 Nov; 199():204-12. PubMed ID: 26204569 [TBL] [Abstract][Full Text] [Related]
38. Editorial overview: Cardiovascular and renal: Novel therapies in peripheral artery disease. Oikonomou E; Tousoulis D Curr Opin Pharmacol; 2018 Apr; 39():iv-vi. PubMed ID: 29941177 [No Abstract] [Full Text] [Related]
39. Synthesis and hypolipidemic activities of 5-thienyl-4-oxazoleacetic acid derivatives. Moriya T; Takabe S; Maeda S; Matsumoto K; Takashima K; Mori T; Takeyama S J Med Chem; 1986 Mar; 29(3):333-41. PubMed ID: 3950914 [TBL] [Abstract][Full Text] [Related]
40. [Fibrate and its perspective as a drug for metabolic syndrome]. Tada N Nihon Rinsho; 2006 Dec; 64 Suppl 9():622-6. PubMed ID: 17458293 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]